These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 7670047)
1. [Circadian variations in the metabolic reaction of human blood lymphocytes to hormonal stimuli in normal conditions and during development of an immunodeficiency]. Trufakin VA; Shurlygina AV; Dergacheva TI; Litvinenko GI Biull Eksp Biol Med; 1995 Feb; 119(2):181-3. PubMed ID: 7670047 [No Abstract] [Full Text] [Related]
2. Thymic hormone in the treatment of cancer. Dardeene M; Bach JF Prog Clin Biol Res; 1989; 288():363-82. PubMed ID: 2654955 [No Abstract] [Full Text] [Related]
3. [Use of a thymus polypeptide preparation to diagnose and correct immune deficiency states in multiple sclerosis]. Golovkin VI; Ankhimova ES; Morozov VG; Khavinson VG Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(2):179-82. PubMed ID: 6201026 [TBL] [Abstract][Full Text] [Related]
4. [Thymic polypeptide factor--thymalin in experiments and in clinical use]. Sofronov BN; Morozov VG; Khavinson VKh; Belokrylov GA Fiziol Cheloveka; 1984; 10(2):229-33. PubMed ID: 6335878 [No Abstract] [Full Text] [Related]
5. [Circadian and seasonal variations of the activity of blood lymphocyte dehydrogenases during secondary immunodeficiency in women with acute inflammatory gynecologic diseases of nonspecific etiology]. Shurlygina AV; Litvinenko GI; Dergacheva TI; Trufakin VA Biull Eksp Biol Med; 1998 May; 125(5):576-8. PubMed ID: 9644564 [No Abstract] [Full Text] [Related]
7. [Treatment of the primary immunodeficiency diseases. Present state of the art (author's transl)]. Fontán G; García Rodríguez MC; Ojeda JA An Esp Pediatr; 1981 Dec; 15(6):563-72. PubMed ID: 6175263 [No Abstract] [Full Text] [Related]
8. [Immunotherapy in the combined treatment of chronic destructive pulmonary tuberculosis]. Ivanova LA Probl Tuberk; 1994; (3):16-9. PubMed ID: 7937662 [TBL] [Abstract][Full Text] [Related]
9. Immunologic reconstitution with bone marrow transplantation and thymic hormones in two patients with severe pure T-cell defects. Businco L; Rossi P; Paganelli R; Seminara R; Aiuti F Birth Defects Orig Artic Ser; 1983; 19(3):281-5. PubMed ID: 6360241 [No Abstract] [Full Text] [Related]
10. [Prospects of using immunocorrective treatment with an active thymus factor (taktivin) in dermatology]. Skripkin IuK; Korotkiĭ NG; Udzhukhu VIu; Arion VIa; Eletskiĭ AIu Vestn Dermatol Venerol; 1986; (4):4-7. PubMed ID: 3487189 [No Abstract] [Full Text] [Related]
11. [Indications for using thymalin in the therapy of children with chronic viral hepatitis B]. Gol'zand IV; Goriacheva LG; Volkov VO; Khavinson VKh; Morozov VG Voen Med Zh; 1986 Mar; (3):27-8. PubMed ID: 3487166 [No Abstract] [Full Text] [Related]
12. [The effect of thymalin on biochemical and immunological indices of lymphocyte differentiation and functional activity]. Khavinson VKh; Kozhemiakin AL; Morozov VG; Kozhemiakin LA Vopr Med Khim; 1990; 36(3):41-3. PubMed ID: 2382426 [TBL] [Abstract][Full Text] [Related]
13. [Use of thymalin in a patient with immunologic deficiency state after thymectomy]. Abdulkadyrov KM; Shcherbakova EG; Khavinson VKh; Morozov VG; Gerbut GB Klin Med (Mosk); 1983 Jun; 61(6):36-8. PubMed ID: 6604193 [No Abstract] [Full Text] [Related]
14. [The immunorehabilitative action of thymohexin in treating patients with chronic brucellosis]. Pokrovskiĭ VI; Suleĭmanov AK; Lebedev VV; Zheludkov MM; Kizenko OA; Shmarov DA; Moskaleva EIu; Karaulov AV Ter Arkh; 1992; 64(11):22-6. PubMed ID: 1293836 [No Abstract] [Full Text] [Related]
15. [Thymalin correction of the immunologic deficiency state in children with congenital 1st and 2d branchial arch syndrome]. Kotov GA; Iarchuk NI; Khavinson VKh; Morozov VG; Kozhemiakin AL Pediatriia; 1983 May; (5):54-5. PubMed ID: 6688298 [No Abstract] [Full Text] [Related]
16. [Development of an experimental tuberculous process in the presence of immune deficiency and immunostimulation]. Shcherbakova NM; Aleksandrova AE; Morozov VG; Podosinnikov IS; Khavinson VKh Biull Eksp Biol Med; 1981 Sep; 92(9):320-2. PubMed ID: 6895337 [TBL] [Abstract][Full Text] [Related]
17. Effect of synthetic thymic hormone (TP5) in children with T-cell immunodeficiencies. Levinsky RJ; Davies EG; Goldstein G Birth Defects Orig Artic Ser; 1983; 19(3):273-6. PubMed ID: 6360239 [No Abstract] [Full Text] [Related]
18. The effect of STF and its analogs on T cells with cellular immunodeficiency. Abiko T; Kumikawa M; Dazai S; Sekino H; Higuchi H Chem Pharm Bull (Tokyo); 1979 Sep; 27(9):2207-11. PubMed ID: 316367 [No Abstract] [Full Text] [Related]
19. Therapy with thymopoietin pentapeptide (TP-5) in 26 patients with primary immunodeficiencies. Aiuti F; Businco L; Fiorilli M; Galli E; Quinti I; Le Moli S; Seminara R; Goldstein G Birth Defects Orig Artic Ser; 1983; 19(3):267-72. PubMed ID: 6360238 [No Abstract] [Full Text] [Related]
20. Thymosin: basic properties and clinical potential in the treatment of patients with immunodeficiency diseases and cancer. Goldstein AL Antibiot Chemother (1971); 1978; 24():47-59. PubMed ID: 350140 [No Abstract] [Full Text] [Related] [Next] [New Search]